{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:37:20Z","timestamp":1792895840897,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000774","name":"United States Department of Defense | Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["HDTRA 1 19 1-0040"],"award-info":[{"award-number":["HDTRA 1 19 1-0040"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000774","name":"United States Department of Defense | Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["HDTRA 1 21 1 0011"],"award-info":[{"award-number":["HDTRA 1 21 1 0011"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000774","name":"United States Department of Defense | Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["HDTRA-1-23-1-0026"],"award-info":[{"award-number":["HDTRA-1-23-1-0026"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["NIGMS R01 GM117263 05"],"award-info":[{"award-number":["NIGMS R01 GM117263 05"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Saxitoxin (STX) is among the most potent toxins known, is classified as a chemical weapon, and is the archetype of the paralytic shellfish toxin (PST) family produced by marine and freshwater harmful algal blooms (HAB). STX causes paralysis and death through inhibition of voltage-gated sodium channels (Na\n                    <jats:sub>V<\/jats:sub>\n                    s), has no antidote, and poses a public health and commercial fishing threat due to its accumulation in seafood and increasing HAB occurrences. Although STX is lethal to varied vertebrates, including humans, certain frogs resist STX poisoning. This phenotype is thought to depend on soluble toxin sponge high-affinity STX binding proteins (saxiphilins, Sxphs) that provide resistance through a competition mechanism different from classic target site ion channel mutation mechanisms. Here, we test this idea and show that a single dose of American bullfrog (\n                    <jats:italic>Rana catesbeiana<\/jats:italic>\n                    ) Sxph (\n                    <jats:italic>Rc<\/jats:italic>\n                    Sxph) is sufficient to counteract STX neurotoxicity and lethality in female mice using paradigms where STX and Sxph are administered together or sequentially in either order. Importantly, this function requires the\n                    <jats:italic>Rc<\/jats:italic>\n                    Sxph high-affinity STX binding site. Our findings provide in vivo validation that Sxphs are toxin sponges that protect against STX poisoning and highlight the potential to harness this protein class as antidotes for PSTs and other toxins.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-75136-z","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:01:50Z","timestamp":1784192510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Saxiphilin functions as a toxin sponge protein that counteracts the effects of saxitoxin poisoning"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3157-4114","authenticated-orcid":false,"given":"Samantha A.","family":"Nixon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8706-4394","authenticated-orcid":false,"given":"Sandra","family":"Zakrzewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6816-5635","authenticated-orcid":false,"given":"Seil","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keli","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5721-2675","authenticated-orcid":false,"given":"Anissa","family":"Bara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4426-2497","authenticated-orcid":false,"given":"Zhou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daynen R.","family":"Goss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9974-3899","authenticated-orcid":false,"given":"Elizabeth R.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7847-1548","authenticated-orcid":false,"given":"J.","family":"Du Bois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5998-4214","authenticated-orcid":false,"suffix":"Jr","given":"Daniel L.","family":"Minor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"75136_CR1","doi-asserted-by":"publisher","first-page":"5760","DOI":"10.1002\/anie.201308235","volume":"53","author":"AP Thottumkara","year":"2014","unstructured":"Thottumkara, A. P., Parsons, W. H. & Du Bois, J. Saxitoxin. Angew. Chem. Int. Ed. Engl. 53, 5760\u20135784 (2014).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"75136_CR2","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.3390\/md8072185","volume":"8","author":"M Wiese","year":"2010","unstructured":"Wiese, M., D\u2019Agostino, P. M., Mihali, T. K., Moffitt, M. C. & Neilan, B. A. Neurotoxic alkaloids: saxitoxin and its analogs. Mar. Drugs 8, 2185\u20132211 (2010).","journal-title":"Mar. Drugs"},{"key":"75136_CR3","doi-asserted-by":"publisher","unstructured":"Smith, Z. J., Arlinghaus, K. M., Boyer, G. L. & Hapeman, C. J. A fresh perspective on cyanobacterial paralytic shellfish poisoning toxins: history, methodology, and toxicology. Mar Drugs https:\/\/doi.org\/10.3390\/md23070271 (2025).","DOI":"10.3390\/md23070271"},{"key":"75136_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1039\/b501296c","volume":"23","author":"LE Llewellyn","year":"2006","unstructured":"Llewellyn, L. E. Saxitoxin, a toxic marine natural product that targets a multitude of receptors. Nat. Prod. Rep. 23, 200\u2013222 (2006).","journal-title":"Nat. Prod. Rep."},{"key":"75136_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.hal.2021.101975","volume":"102","author":"DM Anderson","year":"2021","unstructured":"Anderson, D. M. et al. Marine harmful algal blooms (HABs) in the United States: history, current status and future trends. Harmful Algae 102, 101975 (2021).","journal-title":"Harmful Algae"},{"key":"75136_CR6","doi-asserted-by":"publisher","unstructured":"Anderson, D. M. et al. Evidence for massive and recurrent toxic blooms of Alexandrium catenella in the Alaskan Arctic. Proc. Natl. Acad. Sci. USA. https:\/\/doi.org\/10.1073\/pnas.2107387118 (2021).","DOI":"10.1073\/pnas.2107387118"},{"key":"75136_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41586-023-05760-y","volume":"615","author":"Y Dai","year":"2023","unstructured":"Dai, Y. et al. Coastal phytoplankton blooms expand and intensify in the 21st century. Nature 615, 280\u2013284 (2023).","journal-title":"Nature"},{"key":"75136_CR8","doi-asserted-by":"publisher","unstructured":"Dillon, M. et al. Current trends and challenges for rapid SMART diagnostics at point-of-site testing for marine toxins. Sensors https:\/\/doi.org\/10.3390\/s21072499 (2021).","DOI":"10.3390\/s21072499"},{"key":"75136_CR9","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.2166\/wh.2024.106","volume":"22","author":"S Gawankar","year":"2024","unstructured":"Gawankar, S., Masten, S. J. & Lahr, R. H. Review of the occurrence, treatment technologies, and detection methods for saxitoxins in freshwaters. J. Water Health 22, 1472\u20131490 (2024).","journal-title":"J. Water Health"},{"key":"75136_CR10","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0041-0101(96)00154-7","volume":"35","author":"BD Gessner","year":"1997","unstructured":"Gessner, B. D. et al. Hypertension and identification of toxin in human urine and serum following a cluster of mussel-associated paralytic shellfish poisoning outbreaks. Toxicon 35, 711\u2013722 (1997).","journal-title":"Toxicon"},{"key":"75136_CR11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.toxicon.2009.12.013","volume":"56","author":"SM Etheridge","year":"2010","unstructured":"Etheridge, S. M. Paralytic shellfish poisoning: seafood safety and human health perspectives. Toxicon 56, 108\u2013122 (2010).","journal-title":"Toxicon"},{"key":"75136_CR12","doi-asserted-by":"publisher","first-page":"378","DOI":"10.5811\/westjem.2014.4.16279","volume":"15","author":"W Hurley","year":"2014","unstructured":"Hurley, W., Wolterstorff, C., MacDonald, R. & Schultz, D. Paralytic shellfish poisoning: a case series. West J. Emerg. Med. 15, 378\u2013381 (2014).","journal-title":"West J. Emerg. Med."},{"key":"75136_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.toxicon.2003.11.018","volume":"43","author":"C Garcia","year":"2004","unstructured":"Garcia, C., del Carmen Bravo, M., Lagos, M. & Lagos, N. Paralytic shellfish poisoning: post-mortem analysis of tissue and body fluid samples from human victims in the Patagonia fjords. Toxicon 43, 149\u2013158 (2004).","journal-title":"Toxicon"},{"key":"75136_CR14","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/0041-0101(85)90371-X","volume":"23","author":"SR Davio","year":"1985","unstructured":"Davio, S. R. Neutralization of saxitoxin by anti-saxitoxin rabbit serum. Toxicon 23, 669\u2013675 (1985).","journal-title":"Toxicon"},{"key":"75136_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1006\/taap.1994.1006","volume":"124","author":"BJ Benton","year":"1994","unstructured":"Benton, B. J., Rivera, V. R., Hewetson, J. F. & Chang, F. C. Reversal of saxitoxin-induced cardiorespiratory failure by a burro-raised alpha-STX antibody and oxygen therapy. Toxicol. Appl. Pharm. 124, 39\u201351 (1994).","journal-title":"Toxicol. Appl. Pharm."},{"key":"75136_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/0041-0101(91)90052-S","volume":"29","author":"B Kaufman","year":"1991","unstructured":"Kaufman, B., Wright, D. C., Ballou, W. R. & Monheit, D. Protection against tetrodotoxin and saxitoxin intoxication by a cross-protective rabbit anti-tetrodotoxin antiserum. Toxicon 29, 581\u2013587 (1991).","journal-title":"Toxicon"},{"key":"75136_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202309635","volume":"20","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Protein-loaded cellular nanosponges for dual-biomimicry neurotoxin countermeasure. Small 20, e2309635 (2024).","journal-title":"Small"},{"key":"75136_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0041-0101(91)90039-T","volume":"29","author":"J Mahar","year":"1991","unstructured":"Mahar, J., Lukacs, G. L., Li, Y., Hall, S. & Moczydlowski, E. Pharmacological and biochemical properties of saxiphilin, a soluble saxitoxin-binding protein from the bullfrog (Rana catesbeiana). Toxicon 29, 53\u201371 (1991).","journal-title":"Toxicon"},{"key":"75136_CR19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2210114119","volume":"119","author":"Z Chen","year":"2022","unstructured":"Chen, Z. et al. Definition of a saxitoxin (STX) binding code enables discovery and characterization of the anuran saxiphilin family. Proc. Natl. Acad. Sci. USA 119, e2210114119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75136_CR20","doi-asserted-by":"publisher","unstructured":"Yen, T.-J., Lolicato, M., Thomas-Tran, R., Du Bois, J. & Minor, D. L., Jr. Structure of the Saxiphilin:saxitoxin (STX) complex reveals a convergent molecular recognition strategy for paralytic toxins. Sci. Adv. https:\/\/doi.org\/10.1126\/sciadv.aax2650 (2019).","DOI":"10.1126\/sciadv.aax2650"},{"key":"75136_CR21","doi-asserted-by":"publisher","unstructured":"Caty, S. N. et al. Molecular physiology of chemical defenses in a poison frog. J. Exp. Biol. https:\/\/doi.org\/10.1242\/jeb.204149 (2019).","DOI":"10.1242\/jeb.204149"},{"key":"75136_CR22","doi-asserted-by":"publisher","unstructured":"Abderemane-Ali, F. et al. Evidence that toxin resistance in poison birds and frogs is not rooted in sodium channel mutations and may rely on \u201ctoxin sponge\u201d proteins. J. Gen. Physiol. https:\/\/doi.org\/10.1085\/jgp.202112872 (2021).","DOI":"10.1085\/jgp.202112872"},{"key":"75136_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0022-3565(25)07975-3","volume":"46","author":"M Prinzmetal","year":"1932","unstructured":"Prinzmetal, M., Sommer, H. & Leake, C. D. The pharmacological action of \u201cmussel poison. J. Pharm. Exp. Ther. 46, 63\u201373 (1932).","journal-title":"J. Pharm. Exp. Ther."},{"key":"75136_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0041-0101(67)90114-6","volume":"5","author":"CY Kao","year":"1967","unstructured":"Kao, C. Y. & Fuhrman, F. A. Differentiation of actions of tetrodotoxin and saxitoxin. Toxicon 5, 25\u201334 (1967).","journal-title":"Toxicon"},{"key":"75136_CR25","doi-asserted-by":"publisher","first-page":"12312","DOI":"10.1021\/bi00206a039","volume":"33","author":"LE Llewellyn","year":"1994","unstructured":"Llewellyn, L. E. & Moczydlowski, E. G. Characterization of saxitoxin binding to saxiphilin, a relative of the transferrin family that displays pH-dependent ligand binding. Biochemistry 33, 12312\u201312322 (1994).","journal-title":"Biochemistry"},{"key":"75136_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58903-2","volume":"16","author":"S Zakrzewska","year":"2025","unstructured":"Zakrzewska, S. et al. Structural basis for saxitoxin congener binding and neutralization by anuran saxiphilins. Nat. Commun. 16, 3885 (2025).","journal-title":"Nat. Commun."},{"key":"75136_CR27","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00204-014-1444-y","volume":"90","author":"E Alonso","year":"2016","unstructured":"Alonso, E., Alfonso, A., Vieytes, M. R. & Botana, L. M. Evaluation of toxicity equivalent factors of paralytic shellfish poisoning toxins in seven human sodium channels types by an automated high throughput electrophysiology system. Arch. Toxicol. 90, 479\u2013488 (2016).","journal-title":"Arch. Toxicol."},{"key":"75136_CR28","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1098\/rspb.1997.0124","volume":"264","author":"LE Llewellyn","year":"1997","unstructured":"Llewellyn, L. E., Bell, P. M. & Moczydlowski, E. G. Phylogenetic survey of soluble saxitoxin-binding activity in pursuit of the function and molecular evolution of saxiphilin, a relative of transferrin. Proc. Biol. Sci. 264, 891\u2013902 (1997).","journal-title":"Proc. Biol. Sci."},{"key":"75136_CR29","doi-asserted-by":"publisher","first-page":"5856","DOI":"10.1073\/pnas.1603486113","volume":"113","author":"R Thomas-Tran","year":"2016","unstructured":"Thomas-Tran, R. & Du Bois, J. Mutant cycle analysis with modified saxitoxins reveals specific interactions critical to attaining high-affinity inhibition of hNaV1.7. Proc. Natl. Acad. Sci. USA 113, 5856\u20135861 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75136_CR30","doi-asserted-by":"publisher","first-page":"425","DOI":"10.30802\/AALAS-CM-18-000049","volume":"68","author":"FC Hankenson","year":"2018","unstructured":"Hankenson, F. C., Marx, J. O., Gordon, C. J. & David, J. M. Effects of rodent thermoregulation on animal models in the research environment. Comp. Med. 68, 425\u2013438 (2018).","journal-title":"Comp. Med."},{"key":"75136_CR31","doi-asserted-by":"publisher","unstructured":"Finch, S. C., Boundy, M. J., Webb, N. G. & Harwood, D. T. The effect of experimental protocol on the toxicity of saxitoxin in mice. Toxins https:\/\/doi.org\/10.3390\/toxins15040290 (2023).","DOI":"10.3390\/toxins15040290"},{"key":"75136_CR32","doi-asserted-by":"crossref","unstructured":"Munday, R., Thomas, K., Gibbs, R., Murphy, C. & Quilliam, M. A. Acute toxicities of saxitoxin, neosaxitoxin, decarbamoyl saxitoxin and gonyautoxins 1&4 and 2&3 to mice by various routes of administration. Toxicon 76, 77\u201383 (2013).","DOI":"10.1016\/j.toxicon.2013.09.013"},{"key":"75136_CR33","unstructured":"AOAC. In Official Methods of Analysis of AOAC INTERNATIONAL (ed. Latimer, G. W.) Ch. 49.10.01, C49-87-C49-88 (Oxford University Press, 2023)."},{"key":"75136_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.yebeh.2019.02.029","volume":"95","author":"J Van Erum","year":"2019","unstructured":"Van Erum, J., Van Dam, D. & De Deyn, P. P. PTZ-induced seizures in mice require a revised Racine scale. Epilepsy Behav. 95, 51\u201355 (2019).","journal-title":"Epilepsy Behav."},{"key":"75136_CR35","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","volume":"13","author":"J Cox","year":"2014","unstructured":"Cox, J. et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell Proteom. 13, 2513\u20132526 (2014).","journal-title":"Mol. Cell Proteom."},{"key":"75136_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11095-019-2745-x","volume":"37","author":"A Al Shoyaib","year":"2019","unstructured":"Al Shoyaib, A., Archie, S. R. & Karamyan, V. T. Intraperitoneal route of drug administration: should it be used in experimental animal studies? Pharm. Res. 37, 12 (2019).","journal-title":"Pharm. Res."},{"key":"75136_CR37","doi-asserted-by":"publisher","unstructured":"O\u2019Connell, L. A. et al. Rapid toxin sequestration modifies poison frog physiology. J. Exp. Biol. https:\/\/doi.org\/10.1242\/jeb.230342 (2021).","DOI":"10.1242\/jeb.230342"},{"key":"75136_CR38","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0026-895X(25)13149-0","volume":"33","author":"E Moczydlowski","year":"1988","unstructured":"Moczydlowski, E., Mahar, J. & Ravindran, A. Multiple saxitoxin-binding sites in bullfrog muscle: tetrodotoxin-sensitive sodium channels and tetrodotoxin-insensitive sites of unknown function. Mol. Pharm. 33, 202\u2013211 (1988).","journal-title":"Mol. Pharm."},{"key":"75136_CR39","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1126\/science.6278588","volume":"215","author":"DD Doyle","year":"1982","unstructured":"Doyle, D. D., Wong, M., Tanaka, J. & Barr, L. Saxitoxin binding sites in frog-myocardial cytosol. Science 215, 1117\u20131119 (1982).","journal-title":"Science"},{"key":"75136_CR40","doi-asserted-by":"publisher","unstructured":"Alvarez-Buylla, A. et al. Binding and sequestration of poison frog alkaloids by a plasma globulin. Elife https:\/\/doi.org\/10.7554\/eLife.85096 (2023).","DOI":"10.7554\/eLife.85096"},{"key":"75136_CR41","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nature03415","volume":"434","author":"VM Bricelj","year":"2005","unstructured":"Bricelj, V. M. et al. Sodium channel mutation leading to saxitoxin resistance in clams increases risk of PSP. Nature 434, 763\u2013767 (2005).","journal-title":"Nature"},{"key":"75136_CR42","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1126\/science.aan5061","volume":"357","author":"RD Tarvin","year":"2017","unstructured":"Tarvin, R. D. et al. Interacting amino acid replacements allow poison frogs to evolve epibatidine resistance. Science 357, 1261\u20131266 (2017).","journal-title":"Science"},{"key":"75136_CR43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev-ecolsys-102320-102117","volume":"54","author":"RD Tarvin","year":"2023","unstructured":"Tarvin, R. D., Pearson, K. C., Douglas, T. E., Ram\u00edrez-Casta\u00f1eda, V. & Navarrete, M. J. The diverse mechanisms that animals use to resist toxins. Annu. Rev. Ecol. Evol. S 54, 283\u2013306 (2023).","journal-title":"Annu. Rev. Ecol. Evol. S"},{"key":"75136_CR44","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu, D. et al. The blood-brain barrier: structure, regulation, and drug delivery. Signal Transduct. Target Ther. 8, 217 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"75136_CR45","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.toxicon.2021.11.001","volume":"204","author":"MJ Boundy","year":"2021","unstructured":"Boundy, M. J. et al. Acute toxicity of decarbamoyl gonyautoxin 1&4 to mice by various routes of administration. Toxicon 204, 56\u201363 (2021).","journal-title":"Toxicon"},{"key":"75136_CR46","doi-asserted-by":"publisher","unstructured":"Yotsu-Yamashita, M., Nagaoka, Y., Muramoto, K., Cho, Y. & Konoki, K. Pufferfish saxitoxin and tetrodotoxin binding protein (PSTBP) analogues in the blood plasma of the pufferfish Arothron nigropunctatus, A. hispidus, A. manilensis, and Chelonodon patoca. Mar. Drugs https:\/\/doi.org\/10.3390\/md16070224 (2018).","DOI":"10.3390\/md16070224"},{"key":"75136_CR47","doi-asserted-by":"publisher","first-page":"5937","DOI":"10.1046\/j.0014-2956.2001.02547.x","volume":"268","author":"M Yotsu-Yamashita","year":"2001","unstructured":"Yotsu-Yamashita, M. et al. Purification, characterization, and cDNA cloning of a novel soluble saxitoxin and tetrodotoxin binding protein from plasma of the puffer fish, Fugu pardalis. Eur. J. Biochem. 268, 5937\u20135946 (2001).","journal-title":"Eur. J. Biochem."},{"key":"75136_CR48","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41586-024-08393-x","volume":"639","author":"S Vazquez Torres","year":"2025","unstructured":"Vazquez Torres, S. et al. De novo designed proteins neutralize lethal snake venom toxins. Nature 639, 225\u2013231 (2025).","journal-title":"Nature"},{"key":"75136_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57945-w","volume":"16","author":"M Petersson","year":"2025","unstructured":"Petersson, M. et al. Orally delivered toxin-binding protein protects against diarrhoea in a murine cholera model. Nat. Commun. 16, 2722 (2025).","journal-title":"Nat. Commun."},{"key":"75136_CR50","doi-asserted-by":"publisher","unstructured":"Ahmadi, S. et al. Nanobody-based recombinant antivenom for cobra, mamba and rinkhals bites. Nature https:\/\/doi.org\/10.1038\/s41586-025-09661-0 (2025).","DOI":"10.1038\/s41586-025-09661-0"},{"key":"75136_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2023.102792","volume":"5","author":"Z Chen","year":"2023","unstructured":"Chen, Z., Zakrzewska, S., Hajare, H. S., Du Bois, J. & Minor, D. L. Jr Expression, purification, and characterization of anuran saxiphilins using thermofluor, fluorescence polarization, and isothermal titration calorimetry. STAR Protoc. 5, 102792 (2023).","journal-title":"STAR Protoc."},{"key":"75136_CR52","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/bs.mie.2021.02.013","volume":"653","author":"H Lee","year":"2021","unstructured":"Lee, H., Lolicato, M., Arrigoni, C. & Minor, D. L. Jr Production of K(2P)2.1 (TREK-1) for structural studies. Methods Enzymol. 653, 151\u2013188 (2021).","journal-title":"Methods Enzymol."},{"key":"75136_CR53","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/carcin\/10.5.899","volume":"10","author":"MR Stratton","year":"1989","unstructured":"Stratton, M. R. et al. Characterization of the human cell line TE671. Carcinogenesis 10, 899\u2013905 (1989).","journal-title":"Carcinogenesis"},{"key":"75136_CR54","first-page":"319","volume":"49","author":"MH Ullman-Cullere","year":"1999","unstructured":"Ullman-Cullere, M. H. & Foltz, C. J. Body condition scoring: a rapid and accurate method for assessing health status in mice. Lab Anim. Sci. 49, 319\u2013323 (1999).","journal-title":"Lab Anim. Sci."},{"key":"75136_CR55","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/nprot.2007.261","volume":"2","author":"J Rappsilber","year":"2007","unstructured":"Rappsilber, J., Mann, M. & Ishihama, Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2, 1896\u20131906 (2007).","journal-title":"Nat. Protoc."},{"key":"75136_CR56","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1074\/mcp.M114.044305","volume":"14","author":"R Bruderer","year":"2015","unstructured":"Bruderer, R. et al. Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues. Mol. Cell Proteom. 14, 1400\u20131410 (2015).","journal-title":"Mol. Cell Proteom."},{"key":"75136_CR57","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731\u2013740 (2016).","journal-title":"Nat. Methods"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75136-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75136-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75136-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:01:53Z","timestamp":1784192513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75136-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75136"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75136-z","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"7 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.D. is a cofounder and holds equity shares in TI Therapeutics, Inc., a start-up company interested in developing subtype-selective modulators of sodium channels. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"5934"}}